Search

Your search keyword '"Ponticelli C"' showing total 1,113 results
Start Over Author "Ponticelli C"

Refine your results

more »

more »

more »

more »

more »
1,113 results on '"Ponticelli C"'

53. A randomized study comparing cyclosporine alone vs double and triple therapy in renal transplants. The Italian Multicentre Study Group for Renal Transplantation (SIMTRe). Transplant Proc

Author

PONTICELLI C, TARANTINO A, SEGOLONI GP, CAMBI V, RIZZO G, ALTIERI P, MASTRANGELO F, CASTAGNETO M, SALVADORI M, VALENTE U, COSSU M, FEDERICO, STEFANO, Ponticelli, C, Tarantino, A, Segoloni, Gp, Cambi, V, Rizzo, G, Altieri, P, Mastrangelo, F, Castagneto, M, Salvadori, M, Valente, U, Cossu, M, and Federico, Stefano

Published
1997

54. Antiendothelial cell antibodies: A diagnostic and prognostic tool in Wegener's granulomatosis and micropolyarteritis?

Author

Delpapa, N, Farsi, A, Guidali, L, Raschi, E, Domeneghetti, M, Azzurri, A, Radice, A, Moroni, G, Ponticelli, C, Emmi, L, Tincani, A, Gregorini, G, Passaleva, A, Meroni, P., SINICO, RENATO ALBERTO, Delpapa, N, Farsi, A, Guidali, L, Raschi, E, Domeneghetti, M, Azzurri, A, Radice, A, Sinico, R, Moroni, G, Ponticelli, C, Emmi, L, Tincani, A, Gregorini, G, Passaleva, A, and Meroni, P

Subjects
Vasculitis, anti-endothelial cell antibodies
Published
1997

55. A randomized study comparing three cyclosporine-based regimens in cadaveric renal transplantation. Italian Multicentre Study Group for Renal Transplantation (SIMTRe)

Author

Ponticelli, C., Tarantino, A, Segoloni, Gp, Cambi, V, Rizzo, G, Altieri, P, Mastrangelo, F, Castagneto, M, Salvadori, M, Valente, Umberto, Cossu, M, Federico, S., Ponticelli, C, Tarantino, A, Segoloni, Gp, Cambi, V, Rizzo, G, Altieri, P, Mastrangelo, F, Castagneto, M, Salvadori, M, Valente, U, Cossu, M, and Federico, Stefano

Subjects
Humans, Kidney Transplantation, Immunosuppression, Cyclosporine, SIMTRe
Published
1997

58. Basiliximab significantly reduces acute rejection in renal transplant patients given triple therapy with azathioprine

Author

Ponticelli, C, Yussim, A, Cambi, V, Legendre, C, Rizzo, G, Salvadori, M, Kahn, D, Kashi, S.H, Salmela, K, Fricke, L, Garcia-Martinez, J, Lechler, R, Heemann, U, Monteon, F, Ortuño, J, Amenabar, J.J, Arias, M, Nicholson, M.L, Sperschneider, H, Abendroth, D, Gracida, C, Lao, M, Sever, M.S, Lameire, N, Sanchez-Fructuoso, A, Bascı̀, A, Segoloni, G, Connolly, J, Altieri, P, Akoh, J, Prestele, H, and Girault, D

Published
2001
Full Text
View/download PDF

65. The nephrotic syndrome

Author

Donckerwolcke, R.A.M.G., Stewart Cameron, J., Davison, A, Stewart Cameron, J, Grünfeld, JP, Ponticelli, C, Ritz, E, Ypersele, C van, Winearts, C, Kindergeneeskunde, and RS: NUTRIM School of Nutrition and Translational Research in Metabolism

Published
2004

69. Bicarbonate Dialysis

Author

Salvadeo, A., primary, Cantaluppi, A., additional, Segagni, S., additional, Casati, S., additional, Galli, F., additional, Graziani, G., additional, Poggio, F., additional, Petrella, E., additional, Citterio, A., additional, Bovio, G., additional, and Ponticelli, C., additional

Full Text
View/download PDF

73. Ciclosporin in Cadaveric Renal Transplants

Author

Tarantino, A., primary, Montagnino, G., additional, De Vecchi, A., additional, Egidi, F., additional, Rivolta, E., additional, Berardinelli, L., additional, Vegeto, A., additional, and Ponticelli, C., additional

Full Text
View/download PDF

77. CKD LAB METHODS, PROGRESSION & RISK FACTORS 2

Author

Onuigbo, M., primary, Agbasi, N., additional, Wu, M. J., additional, Shu, K. H., additional, Kugler, E., additional, Cohen, E., additional, Krause, I., additional, Goldberg, E., additional, Garty, M., additional, Jansen, J., additional, De Napoli, I. E., additional, Schophuizen, C. M., additional, Wilmer, M. J., additional, Mutsaers, H. A., additional, Heuvel, L. P., additional, Grijpma, D. W., additional, Stamatialis, D., additional, Hoenderop, J. G., additional, Masereeuw, R., additional, Van Craenenbroeck, A. H., additional, Van Craenenbroeck, E. M., additional, Van Ackeren, K., additional, Vrints, C. J., additional, Hoymans, V. Y., additional, Couttenye, M. M., additional, Erkmen Uyar, M., additional, Tutal, E., additional, Bal, Z., additional, Guliyev, O., additional, Sezer, S., additional, Liu, L., additional, Wang, C., additional, Tanaka, K., additional, Kushiyama, A., additional, Sakai, K., additional, Hara, S., additional, Ubara, Y., additional, Ohashi, Y., additional, Kunugi, Y., additional, Kawazu, S., additional, Untersteller, K., additional, Seiler, S., additional, Rogacev, K. S., additional, Emrich, I. E., additional, Lennartz, C. S., additional, Fliser, D., additional, Heine, G. H., additional, Hoshino, T., additional, Ookawara, S., additional, Miyazawa, H., additional, Ueda, Y., additional, Ito, K., additional, Kaku, Y., additional, Hirai, K., additional, Mori, H., additional, Yoshida, I., additional, Kakuta, S., additional, Hayama, N., additional, Amemiya, M., additional, Okamoto, H., additional, Inoue, S., additional, Tabei, K., additional, Campos, P., additional, Dias, C., additional, Baptista, J., additional, Papoila, A. L., additional, Ortiz, A., additional, Inchaustegui, L., additional, Soto, K., additional, Moon, K. H., additional, Yang, S., additional, Lee, D.-Y., additional, Kim, H. W., additional, Kim, B., additional, Isnard Bagnis, C., additional, Guerraoui, A., additional, Zenasni, F., additional, Idier, L., additional, Chauveau, P., additional, Cerqueira, A., additional, Quelhas-Santos, J., additional, Pestana, M., additional, Choi, J.-Y., additional, Jin, D.-C., additional, Choi, Y.-J., additional, Kim, W.-Y., additional, Nam, S.-A., additional, Cha, J.-H., additional, Cernaro, V., additional, Loddo, S., additional, Lacquaniti, A., additional, Romeo, A., additional, Costantino, G., additional, Montalto, G., additional, Santoro, D., additional, Trimboli, D., additional, Ricciardi, C. A., additional, Lacava, V., additional, Buemi, M., additional, Zawada, A. M., additional, Obeid, R., additional, Geisel, J., additional, Meneses, G. C., additional, Silva Junior, G., additional, Costa, M. F. B., additional, Goncalves, H. S., additional, Daher, E. F., additional, Liborio, A. B., additional, Martins, A. M. C., additional, Ekart, R., additional, Hojs, N., additional, Bevc, S., additional, Hojs, R., additional, Lim, C. S., additional, Hwang, J. H., additional, Chin, H. J., additional, Kim, S., additional, Kim, D. K., additional, Park, J. H., additional, Shin, S. J., additional, Lee, S. H., additional, Choi, B. S., additional, Lemoine, S., additional, Panaye, M., additional, Juillard, L., additional, Dubourg, L., additional, Hadj-Aissa, A., additional, Guebre-Egziabher, F., additional, Vieira, A. P. F., additional, Couto Bem, A. X., additional, Alves, M. P., additional, Stefan, G., additional, Capusa, C., additional, Stancu, S., additional, Margarit, D., additional, Petrescu, L., additional, Nedelcu, E. D., additional, Mircescu, G., additional, Szarejko-Paradowska, A., additional, Rysz, J., additional, Hung, C.-C., additional, Chen, H.-C., additional, Ristovska, V., additional, Grcevska, L., additional, Podesta, M. A., additional, Reggiani, F., additional, Cucchiari, D., additional, Badalamenti, S., additional, Ponticelli, C., additional, Graziani, G., additional, Nouri-Majalan, N., additional, Moghadasimousavi, S., additional, Eshaghyeh, Z., additional, Greenwood, S., additional, Koufaki, P., additional, Maclaughlin, H., additional, Rush, R., additional, Hendry, B. M., additional, Macdougall, I. C., additional, Mercer, T., additional, and Cairns, H., additional

Published
2014
Full Text
View/download PDF

78. Treatment of Primary Glomerulonephritis

Author

Glassock, Richard J., Ponticelli, C., Glassock, Richard J., and Ponticelli, C.

Subjects
Glomerulonephritis--Treatment
Abstract

Primary glomerulonephritis is a common renal disease which may eventually lead to chronic renal failure. Treatment of glomerulonephritis is difficult. In particular the use of glucocorticoids and immunosuppressive drugs require expertise, knowledge of the drugs, and careful monitoring of the patient. Paradoxically, the treatment of glomerulonephritis has become even more complicated in the recent years, after the introduction of a number of newer immunosuppressive drugs. Extensively updated since publication of the first edition in 1997, this comprehensive yet concise guide to the treatment of even the most complex patients with primary glomerular diseases is full of practical information collected and organized in an easy-to-read manner. It encompasses the possible treatments of the different types of primary glomerulonephritis, including diseases intrinsic to the kidney of unknown or uncertain aetiology. Each of the main chapters is devoted to a single primary glomerulonephritis and follows a similar format to allow easy access of information. The book contains not only an evidence-based review of the topic, but also practical recommendations from internationally recognized experts in the field.

Published
2009

88. A randomized study comparing cyclosporine alone vs. double and triple therapy in renal transplants. The Italian Multicenter Study Group for Renal Transplantation (SIMTRe)

Author

Ponticelli, C., Tarantino, A., Segoloni, G. P., Cambi, V., Rizzo, G., Altieri, P., Mastrangelo, F., Castagneto, M., Salvadori, M., Valente, U., Cossu, M., Federico, S., Pisani, Francesco, Montagnino, G., Messina, M., Arisi, L., Carmellini, M., Piredda, G., and Corbetta for the Italian Multicentre Study Group for Renal Transplation, G.

Published
1997

91. Proteinuria and blood pressure as causal components of progression to end-stage renal failure

Author

Locatelli, F., Marcelli, D., Comelli, M., Alberti, D., Graziani, G., Buccianti, G., Redaelli, B., Giangrande, A., Marai, P., Tentori, F., Ponti, R., Ambroso, G., Aroldi, A., Ponticelli, C., Gentile, M. G., Manna, M. G., D'Amico, G., Cresseri, D., Lorenz, M., Vigano, M. R., Bonoldi, G., Castighoni, A., Donati, D., Gastaldi, L., Como, G., Silenzio, R., Brancaccio, D., Gotti, E., Mecca, G., Dozio, B., Cairo, G., Conte, F., Meroni, M., Sessa, A., Picardi, L., Villa, G., Salvadeo, A., Cosci, P., Surian, M., Depetri, C., Mileti, M., Bracchi, O., Giraldi, B., Grassi, C., Reina, E., Malcangi, U., Ramello, A., Baruffaldi, M., Baroni, C., Guida, G. E., Verzetti, G., Costantino, A., Vallino, F., Bassi, S., Poiatti, P., Castellani, A., Gaiani, G., Lusvarghi, E., Francucci, B. M., and Battiros, G.

Subjects
Proteinuria, Multicentre, End-stage renal failure, Blood pressure, Hypertension, Prognostic factors, Prospective randomized trial
Published
1996

93. Rapporto sul Registro Nazionale delle Biopsie Renali (1987-1993)

Author

Cazzato, F., Della Volpe, M., Pallotta, G., Bibiano, L., Bizzarri, D., Iannaccone, S., Messina, G., Caramello, E., Pasquali, S., Strada, A., Pani, A., Bonadonna, A., Dugo, M., Spanti, D., Palmieri, Pf, Vallino, F., Quarenchi, M., Bufano, G., Storari, A., Passione, A., Garibotto, G., Patruno, P., Pozzi, C., Farina, M., Tarachini, R., Lupi, Gp, Ponticelli, C., Furci, L., Grasso, C., Sorice, P., Cusaro, C., Bono, M., Cambi, V., Buoncristiani, U., Cioni, L., Tesio, F., Fusaroli, M., Zoccali, C., Rustichelli, R., Cagnoli, L., Cinotti, Ga, Stallone, C., Pedrini, L., Scatizzi, A., Roccatello, Dario, Piccoli, G., Manganaro, M., Rovati, C., Borghi, M., Maschio, G., and Ancarani, A.

Published
1996

96. Hydroxychloroquine in systemic lupus erythematosus (SLE)

Author

Ponticelli, C. and Moroni, G.

Abstract

ABSTRACTIntroduction: Hydroxychloroquine (HCQ) is an alkalinizing lysosomatropic drug that accumulates in lysosomes where it inhibits some important functions by increasing the pH. HCQ has proved to be effective in a number of autoimmune diseases including systemic lupus erythematosus (SLE).Areas covered: In this review the mechanisms of action, the efficacy, and the safety of HCQ in the management of patients with SLE have been reviewed. HCQ may reduce the risk of flares, allow the reduction of the dosage of steroids, reduce organ damage, and prevent the thrombotic effects of anti-phospholipid antibodies. The drug is generally safe and may be prescribed to pregnant women. However, some cautions are needed to prevent retinopathy, a rare but serious complication of the prolonged use of HCQ.Expert opinion: HCQ may offer several advantages not only in patients with mild SLE but can also exert important beneficial effects in lupus patients with organ involvement and in pregnant women. The drug has a low cost and few side effects. These characteristics should encourage a larger use of HCQ, also in lupus patients with organ involvement.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results